A group of doctors at the University of Cambridge is pioneering a novel blood test designed to diagnose prostate cancer with increased precision. This advancement could potentially pave the way
A group of doctors at the University of Cambridge is pioneering a novel blood test designed to diagnose prostate cancer with increased precision. This advancement could potentially pave the way
Prostate cancer screening for men over 50 could transform outcomes in Britain, according to one of the largest trials ever conducted in Europe. The latest data from the European Randomised
The landscape of prostate cancer diagnosis is on the cusp of transformation as the NHS introduces rapid new trials deploying artificial intelligence. Men presenting with possible symptoms of prostate cancer






